Home PFE
42.43
  Price1.53%   -0.66
 
loading
Oct-07-22 06:13AM Zacks Value Trader Highlights: ExxonMobil, Pfizer, Union Pacific, Cisco and PNC FinancialZacks Investment Research
Oct-06-22 03:44AM 300th Episode: Buffett's 2008 LessonsZacks Investment Research
10:54AM Biohaven (BHVN) Stock Up on Spin-Off Transaction FinalizationZacks Investment Research
Oct-06-22 09:10AM 3 Top Dividend Stocks to Maximize Your Retirement IncomeZacks Investment Research
Oct-05-22 04:45AM Why Biohaven Stock Skyrocketed Again TodayThe Motley Fool
09:53AM 3 of the Best Dividend Stocks to Buy in OctoberThe Motley Fool
Oct-05-22 09:15AM GSK's Key Drugs to Drive Sales in a Sluggish Second HalfZacks Investment Research
Oct-04-22 12:29PM Why Biohaven Stock Is Soaring TodayThe Motley Fool
09:40AM Why Novavax's (NVAX) COVID Vaccine Struggles for Market Share?Zacks Investment Research
Oct-03-22 08:24AM Should Investors Buy Bristol Myers Squibb Stock?Zacks Investment Research
05:45AM Pfizer (PFE) Gains But Lags Market: What You Should KnowZacks Investment Research
Oct-02-22 10:30AM Got $1,000? 2 Dividend Stocks to Buy and Hold for DecadesThe Motley Fool
Oct-01-22 10:37AM 3 Growth Stocks Poised to SkyrocketThe Motley Fool
06:00AM Here's Why the Post-Pandemic World May Be Even Better for This Vaccine MakerThe Motley Fool
Sep-30-22 01:04AM Biohaven Pharma's (BHVN) ALS Study Fail to Meet Both EndpointsZacks Investment Research
12:52PM 1 in 5 of Americans don't know about new omicron-targeting COVID boosters, survey findsMarketWatch
Sep-30-22 09:10AM Improve Your Retirement Income with These 3 Top-Ranked Dividend StocksZacks Investment Research
Sep-29-22 12:00PM EMA Accepts Moderna's (MRNA) Filing for Omicron BA.4, BA.5 BoosterZacks Investment Research
11:58AM Pfizer (PFE), BNTX Seek EU Nod for Omicron Booster in KidsZacks Investment Research
Sep-28-22 09:00AM Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending StockZacks Investment Research
08:04AM Canada to scrap mask mandate on planes, joining Japan, Hong Kong and U.A.E. in lifting COVID restrictionsMarketWatch
Sep-27-22 12:46PM Pfizer (PFE) Seeks FDA Approval for Omicron Booster in KidsZacks Investment Research
11:04AM Canada to scrap mask mandate on planes, joining Japan, Hong Kong and U.A.E. in lifting COVID restrictionsMarketWatch
Sep-27-22 06:26AM Pfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11MarketWatch
05:01AM What are single-stock ETFs, and should you buy them? ‘They’re not for the faint of heart.’MarketWatch
Sep-26-22 05:45AM Pfizer (PFE) Stock Moves -0.57%: What You Should KnowZacks Investment Research
02:30AM Hot Penny Stocks To Watch As The Stock Market Crash ContinuesPennyStocks
Sep-26-22 01:23AM Pfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11MarketWatch
12:39PM Valneva (VALN) Stock Down 66% in the Past 6 Months: Here's WhyZacks Investment Research
Sep-26-22 11:11AM Pfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11MarketWatch
06:00AM Down 85%, Is There Any Hope for This Struggling Vaccine Stock?The Motley Fool
Sep-25-22 06:07AM Novavax Downgraded by JPMorgan Chase. Time to Sell?The Motley Fool
Sep-24-22 10:11AM 'Reshoring' is poised to boost U.S. companies bringing business back home. Shares of these 17 companies will benefit.MarketWatch
Sep-23-22 11:02AM Spero (SPRO) Skyrockets 168% on Licensing Deal With GSKZacks Investment Research
10:51AM Why Novavax (NVAX) Stock Was Down 13% on ThursdayZacks Investment Research
Sep-23-22 09:10AM Improve Your Retirement Income with These 3 Top-Ranked Dividend StocksZacks Investment Research
07:20AM Health official says updated COVID-19 boosters likely to be available in weeks for elementary school-age childrenMarketWatch
Sep-22-22 04:34AM Industries That Thrive During RecessionsThe Motley Fool
10:43AM Health official says updated COVID-19 boosters likely to be available in weeks for elementary school-age childrenMarketWatch
Sep-22-22 04:32AM Novavax Remains A Risk-On Stock In A Risk-Off MarketInvesting.com
Sep-21-22 11:42AM Moderna expects the shortage of its updated COVID-19 booster to soon be resolvedMarketWatch
06:18AM The Zacks Analyst Blog Highlights Pfizer, BioNTech, Moderna and NovavaxZacks Investment Research
Sep-20-22 02:45AM Analysts Put Alnylam On Upside Catalyst Watch Ahead Of Upcoming Data From Lead ProgramBenzinga
10:14AM Vaccine Stocks Down After Biden Says Pandemic is OverZacks Investment Research
Sep-20-22 10:05AM 2 Cheap Growth Stocks to Buy and Hold for YearsThe Motley Fool
09:53AM Could This Be Pfizer's Next Billion-Dollar Vaccine?The Motley Fool
Sep-20-22 08:36AM Health experts dismayed by President Biden's view that the pandemic is over: 'Hell no — not even close'MarketWatch
07:15AM Health experts dismayed by President Biden's view that the pandemic is over: 'Hell no — not even close'MarketWatch
Sep-20-22 05:31AM Can This Tiny Biotech Take On Pfizer?The Motley Fool
Sep-19-22 06:01AM Why Moderna Stock Dropped TodayThe Motley Fool
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It operates in two segments, Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). The IH segment focuses on the development and commercialization of medicines and vaccines, and consumer healthcare products in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases, as well as consumer healthcare, such as over-the-counter brands comprising dietary supplements, pain management, gastrointestinal, and respiratory and personal care. This segment offers products primarily under the Prevnar 13/Prevenar 13, Xeljanz, Eliquis, Lyrica, Enbrel, Ibrance, Xtandi, Advil, and Centrum brands. The EH segment offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives. It provides products under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Pristiq, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit brands. This segment also engages in the research and development, as well as contract manufacturing activities. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. Pfizer Inc. has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; Immunicum AB (publ); Immutep Limited; BioNTech AG; Neofluidics, LLC; Kite Pharma, Inc.; Leap Therapeutics, Inc.; Nektar Therapeutics; and Zenith Epigenetics Ltd., as well as development agreement with Antares Pharma, Inc. It also has a collaboration agreement with Aileron Therapeutics, Inc. The company was founded in 1849 and is headquartered in New York, New York.
Cap:    |  Volume (24h):